AI-Native Quality Assurance Automation Engineer

Explore our press page to learn more about Mastercard's latest announcements, press releases, news, partnerships, and more.

BVNK achieves SOC 1 Type II. Independent audit validates financial controls. Bvnk Ltd is thrilled to announce that BVNK has achieved SOC 1 Type II certification - a critical milestone that validates how Bvnk Ltd protect your financial assets and ensure transaction accuracy. SOC 1 Type II is the gold standard for financial controls. It means an independent auditor has rigorously examined its systems to verify that money is protected, balances are accurate, and transactions are processed reliably. Over the past 6 months, this examination covered 17 critical financial control areas across its platform. The result: zero exceptions noted. SOC 1 Type II complements its SOC 2 Type II certification. Together, they demonstrate comprehensive, enterprise-grade controls - technical security and financial integrity. For enterprise customers and regulated institutions, this combination provides the independent assurance your auditors require. Assets and balances are independently verified. The audit verified that digital assets held with BVNK are protected by multiple layers of cryptographic controls. Private keys are distributed across geographically separated locations and backed by insurance coverage - meaning no single person can unilaterally move your funds. Your account balances are reconciled daily against external bank statements, and transactions are automatically validated and recorded. These comprehensive financial controls ensure money is where Bvnk Ltd say it is - and that your auditors can verify that too. Platform reliability and accessibility of funds. Bvnk Ltd maintain critical systems with daily backups and cross-region replication. If its primary data center fails, a backup automatically takes over. The auditor confirmed that during the 6-month audit period, Bvnk Ltd had zero significant system incidents. They also confirmed that Bvnk Ltd maintain sufficient reserves to cover 100% of customer balances, enabling withdrawals to be processed without delays. What this means for you. SOC 1 Type II certification is what enterprise customers and regulated institutions look for when vetting a payments provider - and what their auditors require. It means an independent auditor has examined its financial controls comprehensively and confirmed they're working reliably. Money is secure, balances are accurate, and transactions are processed with audit-grade controls. If you're subject to your own SOC 1 requirements or regulatory audits, you can now confidently demonstrate that your critical financial supplier meets the highest standards of control and compliance. Want to learn more? Visit its Trust Center to view the full SOC 1 Type II report or explore its other compliance certifications (SOC 2 Type II, ISO 27001:2022, DORA).

Visa (V) vs. Mastercard (MA): $2.4B BioCatch acquisition escalates the payments security war. Published on August 6, 2026 at 6:15 pm by maham fatima in hedge funds, news. Visa (NYSE:V) said on August 3 that it would buy fraud intelligence provider BioCatch for $2.4 billion in cash, its latest move to build out cybersecurity tools for the banks and merchants that run on its network. The deal targets a problem that keeps getting more expensive: account takeovers and scams now cost the global economy more than $1 trillion a year, and Visa says AI is helping fraudsters pull those attacks off at a scale banks have not seen before. The bull case: closing the fraud-tech gap. BioCatch, founded in 2011 in Tel Aviv, built its business on behavioral biometrics, tracking keystrokes, touch gestures and device handling to tell a real customer apart from a fraudster in real time. It already protects 1.8 billion devices and 760 million users across more than 350 banking clients in 21 countries, and under Permira's ownership since 2024, its revenue and gross profit both roughly tripled. Folding that into Visa's rails, which connect nearly 14,500 financial institutions and process more than 329 billion transactions worth over $17 trillion a year, gives the technology a far bigger stage than it had on its own. The deal also closes a gap investors had been watching. Evercore analyst Adam Frisch said the market would welcome the news, noting that many had pointed to Mastercard's Recorded Future as the best-in-class tool in this category. Visa has now put real money behind catching up, on top of the more than $13 billion it has spent on technology and infrastructure to fight fraud over the past five years, including its 2024 purchase of Featurespace. Andrew Torre, Visa's president of value-added services, said BioCatch will help clients stop fraud before it reaches the point of payment, a division that grew revenue 34% last quarter, the fastest-growing part of Visa's business. The bear case: the clock and the competition. The timeline cuts against the urgency of the pitch. The BioCatch deal is not expected to close until the end of Visa's fiscal second quarter of 2027, so the gap Frisch described stays open for months while Mastercard's Recorded Future, in place since a $2.65 billion purchase in 2024, keeps running. On the same day Visa announced the BioCatch purchase, Mastercard (NYSE:MA) completed its own acquisition of stablecoin infrastructure platform BVNK, and on July 23 it rolled out new issuer and clearing controls across its virtual card network, with Citi the first bank live on both. Visa's underlying business still runs at a wider margin and a slightly higher cross-border volume growth rate (13% to Mastercard's 12%) last quarter, but Mastercard continues to carve out strong momentum elsewhere, led by a 20% jump in value-added services revenue. None of that is derailed by a single acquisition, and $2.4 billion in cash still has to clear regulators before it changes either company's fraud numbers. Market sentiment: Visa vs. Mastercard. Both card networks are leaning on acquisitions to build out their security and infrastructure stacks at once. Mastercard completed its BVNK stablecoin deal as Visa announced BioCatch, and its virtual card security push landed two weeks earlier, so investors are pricing two companies making parallel bets rather than one chasing the other. Hedge fund ownership of Visa fell from 184 to 181 funds last quarter, while Mastercard funds rose from 150 to 157, a split in institutional conviction that favors Mastercard's momentum. As of August 4, Visa trades at a forward P/E of 24.45 versus Mastercard's 29.15, so the market is asking Mastercard to prove more growth. Short interest sits at 1.39% of Visa's float against 1.04% for Mastercard. Conclusion. The BioCatch deal gives Visa a meaningful position in fraud prevention at a time when its cross-border and value-added services businesses are already growing strongly. Mastercard's recent earnings growth has outpaced Visa's, but the $2.4 billion acquisition still needs to demonstrate that AI fraud detection can translate into material revenue and attractive returns. Until then, BioCatch strengthens Visa's long-term payments strategy more clearly than it changes the company's near-term financial outlook. While we acknowledge the risk and potential of V and MA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than V and MA and that has 10,000% upside potential, check out our report about this cheapest AI stock.